Amgen bought Ch...
login
Shares
Bonds
🔥Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
ChemoCentryx
Amgen bought ChemoCentryx
10/20/22 at 16:16
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.
ChemoCentryx
Review
Source:
investors.amgen.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Mondelēz International reported for 3 months of 2023
4/28/23
MDLZ
Gilead reports on 3 months of 2023
4/28/23
GILD
Amazon reported for 3 months of 2023
4/28/23
AMZN
Intel reported for 3 months of 2023
4/28/23
INTC
EL5-Energo in Q1 decreased energy generation by 6.7%
4/28/23
ELFV
European Electrotechnics reported for 2022 by IFRS
4/27/23
EELT
ТNS Energo Rostov-on-Don reported for 3 months of 2023 according to RAS
4/27/23
RTSB
Plant of ecological equipment and eco-food DIIOD reported for 2022 by IFRS
4/27/23
DIOD
Plant of ecological equipment and eco-food DIIOD reported for 2022 by IFRS
4/27/23
DIOD
Arsagera reported for 2022 according to IFRS
4/27/23
ARSA
«
Previous
633
634
635
636
637
638
639
640
641
642
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Русский (РФ)